1.2 Million Invested in MS Care and Innovation
Novartis Pharmaceuticals Canada Inc. (Novartis) announced today an investment of 1.2 million in Alberta to collaborate with the Alberta government to advance care and innovation in multiple sclerosis (MS). This investment by Novartis, for MS research, marks the first collaboration under a memorandum of understanding (MOU) between Novartis and the Alberta government intended to stimulate health research and innovation in the province of Alberta.
The 1.2-million Novartis investment will support research for the treatment of MS. The goal is to look at novel innovations, evaluation methods and care pathways and to translate these into practice to further the understanding of the disease and care of MS patients.
For more details, see the FULL ARTICLE.
Latest News - view all
When it heals the soul but hurts the body: Finding a healthy balance
Posted: Jan 18, 2019By: Kristina Marie Dizard When it heals the soul but hurts the body: Finding a healthy balance. ...
Event Updates - view all
Posted: Aug 05, 2020Join us September 4th for our reimagined gala for 2020, ...
Posted: May 12, 2014Please join us for an opportunity to hear from our ...
Posted: Apr 07, 2014Please join us on May 2, 2014 at the Hyatt ...
Comments